메뉴 건너뛰기




Volumn 123, Issue 17, 2010, Pages 2471-2474

Viewpoint febuxostat, a nonpurine selective inhibitor of xanthine oxidase: Apromising medical therapy for chronic heart failure?

Author keywords

Chronic heart failure; Febuxostat; Reactive oxygen species; Signaling pathways; Xanthine oxidase inhibitors

Indexed keywords

ALLOPURINOL; FEBUXOSTAT; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR; THIAZOLE DERIVATIVE;

EID: 79851480604     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.17.033     Document Type: Article
Times cited : (3)

References (47)
  • 3
    • 0037155054 scopus 로고    scopus 로고
    • Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart
    • Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 2002; 90: 297-304.
    • (2002) Circ Res , vol.90 , pp. 297-304
    • Saavedra, W.F.1    Paolocci, N.2    John, S.M.E.3    Skaf, M.W.4    Stewart, G.C.5    Xie, J.S.6
  • 4
    • 0035814786 scopus 로고    scopus 로고
    • Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing induced heart failure
    • Ukai T, Cheng CP, Tachibana H, Igawa A, Zhang ZS, Cheng HJ, et al. Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing induced heart failure. Circulation 2001; 103: 750-755.
    • (2001) Circulation , vol.103 , pp. 750-755
    • Ukai, T.1    Cheng, C.P.2    Tachibana, H.3    Igawa, A.4    Zhang, Z.S.5    Cheng, H.J.6
  • 5
    • 0033520357 scopus 로고    scopus 로고
    • Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing induced heart failure
    • Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing induced heart failure. Circ Res 1999; 5: 437-445.
    • (1999) Circ Res , vol.5 , pp. 437-445
    • Ekelund, U.E.1    Harrison, R.W.2    Shokek, O.3    Thakkar, R.N.4    Tunin, R.S.5    Senzaki, H.6
  • 6
    • 0035856508 scopus 로고    scopus 로고
    • Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
    • Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 20: 2407-2411.
    • (2001) Circulation , vol.20 , pp. 2407-2411
    • Cappola, T.P.1    Kass, D.A.2    Nelson, G.S.3    Berger, R.D.4    Rosas, G.O.5    Kobeissi, Z.A.6
  • 7
    • 23644437342 scopus 로고    scopus 로고
    • Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure
    • Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, et al. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol 2005; 3: 531-536.
    • (2005) J Mol Cell Cardiol , vol.3 , pp. 531-536
    • Amado, L.C.1    Saliaris, A.P.2    Raju, S.V.3    Lehrke, S.4    John, S.M.5    Xie, J.6
  • 8
    • 20844461656 scopus 로고    scopus 로고
    • Allopurinol attenuates leftventricular remodeling and dysfunction after experimental myocardial infarction: A new action for an old drug?
    • Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, et al. Allopurinol attenuates leftventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug? Circulation 2004; 15: 2175-2179.
    • (2004) Circulation , vol.15 , pp. 2175-2179
    • Engberding, N.1    Spiekermann, S.2    Schaefer, A.3    Heineke, A.4    Wiencke, A.5    Muller, M.6
  • 10
    • 33644630969 scopus 로고    scopus 로고
    • Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy
    • Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, et al. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 2006; 2: 271-279.
    • (2006) Circ Res , vol.2 , pp. 271-279
    • Minhas, K.M.1    Saraiva, R.M.2    Schuleri, K.H.3    Lehrke, S.4    Zheng, M.5    Saliaris, A.P.6
  • 12
    • 1642484244 scopus 로고    scopus 로고
    • Xanthine oxidoreductase and cardiovascular disease-molecular mechanisms andpathophysiologic implications
    • Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease-molecular mechanisms andpathophysiologic implications. J Physiol 2004; 555: 589-606.
    • (2004) J Physiol , vol.555 , pp. 589-606
    • Berry, C.E.1    Hare, J.M.2
  • 13
    • 9544229815 scopus 로고    scopus 로고
    • Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31P-MRS study
    • Zhang J, Wilke N, Wang Y, Zhang Y, Wang C, Eijgelshoven MH, et al. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31P-MRS study. Circulation 1996; 94: 1089-1100.
    • (1996) Circulation , vol.94 , pp. 1089-1100
    • Zhang, J.1    Wilke, N.2    Wang, Y.3    Zhang, Y.4    Wang, C.5    Eijgelshoven, M.H.6
  • 14
    • 0030819144 scopus 로고    scopus 로고
    • Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
    • Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-2196.
    • (1997) Circulation , vol.96 , pp. 2190-2196
    • Neubauer, S.1    Horn, M.2    Cramer, M.3    Harre, K.4    Newell, J.B.5    Peters, W.6
  • 16
    • 0037905740 scopus 로고    scopus 로고
    • 2 regulates cardiac myocyte phenotype viaconcentration-dependent activation of distinct kinase pathways
    • Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H2O2 regulates cardiac myocyte phenotype viaconcentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003; 35: 615-621.
    • (2003) J Mol Cell Cardiol , vol.35 , pp. 615-621
    • Kwon, S.H.1    Pimentel, D.R.2    Remondino, A.3    Sawyer, D.B.4    Colucci, W.S.5
  • 17
    • 0036791698 scopus 로고    scopus 로고
    • Activation of NADPH oxidase during progression of cardiac hypertrophy tofailure
    • Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy tofailure. Hypertension 2002; 40: 477-484.
    • (2002) Hypertension , vol.40 , pp. 477-484
    • Li, J.M.1    Gall, N.P.2    Grieve, D.J.3    Chen, M.4    Shah, A.M.5
  • 18
    • 0037028866 scopus 로고    scopus 로고
    • The antioxidant N-2-mercaptopropionylglycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
    • Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, et al. The antioxidant N-2-mercaptopropionylglycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 2002; 39: 907-912.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 907-912
    • Date, M.O.1    Morita, T.2    Yamashita, N.3    Nishida, K.4    Yamaguchi, O.5    Higuchi, Y.6
  • 19
    • 0036487320 scopus 로고    scopus 로고
    • Involvement of reactive oxygenspecies-mediated NF-kappa B activation in TNF-alphainduced cardiomyocyte hypertrophy
    • Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O, et al. Involvement of reactive oxygenspecies-mediated NF-kappa B activation in TNF-alphainduced cardiomyocyte hypertrophy. J Mol Cell Cardiol 2002; 34: 233-240.
    • (2002) J Mol Cell Cardiol , vol.34 , pp. 233-240
    • Higuchi, Y.1    Otsu, K.2    Nishida, K.3    Hirotani, S.4    Nakayama, H.5    Yamaguchi, O.6
  • 20
    • 0035980171 scopus 로고    scopus 로고
    • Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes
    • Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001; 89: 453-460.
    • (2001) Circ Res , vol.89 , pp. 453-460
    • Pimentel, D.R.1    Amin, J.K.2    Xiao, L.3    Miller, T.4    Viereck, J.5    Oliver-Krasinski, J.6
  • 21
    • 0344665681 scopus 로고    scopus 로고
    • Regulation of calcineurin by oxidative stress
    • Ghosh MC, Wang X, Li S, Klee C. Regulation of calcineurin by oxidative stress. Methods Enzymol 2003; 366: 289-304.
    • (2003) Methods Enzymol , vol.366 , pp. 289-304
    • Ghosh, M.C.1    Wang, X.2    Li, S.3    Klee, C.4
  • 22
    • 0037969707 scopus 로고    scopus 로고
    • ASK1 associates with troponin T and induces troponin Tphosphorylation and contractile dysfunction incardiomyocytes
    • He X, Liu Y, Sharma V, Dirksen RT, Waugh R, Sheu SS, et al. ASK1 associates with troponin T and induces troponin Tphosphorylation and contractile dysfunction incardiomyocytes. Am J Pathol 2003; 163: 243-251.
    • (2003) Am J Pathol , vol.163 , pp. 243-251
    • He, X.1    Liu, Y.2    Sharma, V.3    Dirksen, R.T.4    Waugh, R.5    Sheu, S.S.6
  • 23
    • 14644442283 scopus 로고    scopus 로고
    • Oxygen, oxidative stress, hypoxia, and heart failure
    • Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-508.
    • (2005) J Clin Invest , vol.115 , pp. 500-508
    • Giordano, F.J.1
  • 25
  • 27
    • 0036889545 scopus 로고    scopus 로고
    • Lipid peroxidation-derived aldehydes and oxidative stress in thefailing heart: Role of aldose reductase
    • Srivastava S, Chandrasekar B, Bhatnagar A, Prabhu SD. Lipid peroxidation-derived aldehydes and oxidative stress in thefailing heart: role of aldose reductase. Am J Physiol Heart Circ Physiol 2002; 283: H2612-H2619.
    • (2002) Am J Physiol Heart Circ Physiol , vol.283
    • Srivastava, S.1    Chandrasekar, B.2    Bhatnagar, A.3    Prabhu, S.D.4
  • 28
    • 0032574631 scopus 로고    scopus 로고
    • Elevated levels of 8-iso-prostaglandin F2alpha in pericardialfluid of patients with heart failure: A potential role for in vivooxidant stress in ventricular dilatation and progression to heart failure
    • Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardialfluid of patients with heart failure: a potential role for in vivooxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998; 97: 1536-1539.
    • (1998) Circulation , vol.97 , pp. 1536-1539
    • Mallat, Z.1    Philip, I.2    Lebret, M.3    Chatel, D.4    Maclouf, J.5    Tedgui, A.6
  • 29
    • 0345258510 scopus 로고    scopus 로고
    • Regulation of hypertrophicand apoptotic signaling pathways by reactive oxygen species in cardiac myocytes
    • Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophicand apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 2003; 5: 731-740.
    • (2003) Antioxid Redox Signal , vol.5 , pp. 731-740
    • Sabri, A.1    Hughie, H.H.2    Lucchesi, P.A.3
  • 30
    • 0033001511 scopus 로고    scopus 로고
    • Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rathearts
    • Ferdinandy P, Panas D, Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rathearts. Am J Physiol 1999; 276: H1861-H1867.
    • (1999) Am J Physiol , vol.276
    • Ferdinandy, P.1    Panas, D.2    Schulz, R.3
  • 31
    • 0033900011 scopus 로고    scopus 로고
    • Peroxynitrite is a major contributor to cytokine-inducedmyocardial contractile failure
    • Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-inducedmyocardial contractile failure. Circ Res 2000; 87: 241-247.
    • (2000) Circ Res , vol.87 , pp. 241-247
    • Ferdinandy, P.1    Danial, H.2    Ambrus, I.3    Rothery, R.A.4    Schulz, R.5
  • 32
    • 0037155054 scopus 로고    scopus 로고
    • Imbalance between xanthine oxidase and nitricoxide synthase signaling pathways underlies mechano-energetic uncoupling in the failing heart
    • Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, et al. Imbalance between xanthine oxidase and nitricoxide synthase signaling pathways underlies mechano-energetic uncoupling in the failing heart. Circ Res. 2002; 90: 297-304.
    • (2002) Circ Res , vol.90 , pp. 297-304
    • Saavedra, W.F.1    Paolocci, N.2    John, S.M.E.3    Skaf, M.W.4    Stewart, G.C.5    Xie, J.S.6
  • 35
    • 8844261207 scopus 로고    scopus 로고
    • Chronic treatment with allopurinol boosts survival and cardiaccontractility in murine postischemic cardiomyopathy
    • Stull LB, Leppo MK, Szweda L, Gao WD, Marban E. Chronic treatment with allopurinol boosts survival and cardiaccontractility in murine postischemic cardiomyopathy. Circ Res 2004; 95: 1005-1011.
    • (2004) Circ Res , vol.95 , pp. 1005-1011
    • Stull, L.B.1    Leppo, M.K.2    Szweda, L.3    Gao, W.D.4    Marban, E.5
  • 36
    • 14644423890 scopus 로고    scopus 로고
    • NO/redox disequilibrium in the failingheart and cardiovascular system
    • Hare JM, Stamler JS. NO/redox disequilibrium in the failingheart and cardiovascular system. J Clin Invest 2005; 115:509-517.
    • (2005) J Clin Invest , vol.115 , pp. 509-517
    • Hare, J.M.1    Stamler, J.S.2
  • 37
    • 8644244680 scopus 로고    scopus 로고
    • Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitationcontractioncoupling
    • Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD, et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitationcontractioncoupling. Proc Natl Acad Sci U S A 2004; 101: 15944-15948.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 15944-15948
    • Khan, S.A.1    Lee, K.2    Minhas, K.M.3    Gonzalez, D.R.4    Raju, S.V.5    Tejani, A.D.6
  • 38
    • 9344267711 scopus 로고    scopus 로고
    • NO and superoxide: Opposite ends of the seesaw in cardiac contractility
    • Bonaventura J, Gow A. NO and superoxide: opposite ends of the seesaw in cardiac contractility. Proc Natl Acad Sci USA 2004; 101: 16403-16404.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 16403-16404
    • Bonaventura, J.1    Gow, A.2
  • 39
    • 0037461111 scopus 로고    scopus 로고
    • Uric acid and survival in chronic heartfailure: Validation and application in metabolic, functional, and hemodynamic staging
    • Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heartfailure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107: 1991-1997.
    • (2003) Circulation , vol.107 , pp. 1991-1997
    • Anker, S.D.1    Doehner, W.2    Rauchhaus, M.3    Sharma, R.4    Francis, D.5    Knosalla, C.6
  • 40
    • 12344285284 scopus 로고    scopus 로고
    • Uric acid in chronic heart failure
    • Doehner W, Anker SD. Uric acid in chronic heart failure. Semin Nephrol 2005; 25: 61-66.
    • (2005) Semin Nephrol , vol.25 , pp. 61-66
    • Doehner, W.1    Anker, S.D.2
  • 41
    • 0032563386 scopus 로고    scopus 로고
    • 2+_itizing property of xanthine oxidase inhibitors
    • 2+_itizing property of xanthine oxidase inhibitors. Circ Res 1998; 83: 423-430.
    • (1998) Circ Res , vol.83 , pp. 423-430
    • Perez, N.G.1    Gao, W.D.2    Marban, E.3
  • 42
    • 17144396355 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics offebuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
    • Mayer MD, Khosravan R, Vernillet L, Wu JT, Joseph-Ridge N, Mulford DJ. Pharmacokinetics and pharmacodynamics offebuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am J Ther 2005;12: 22-34.
    • (2005) Am J Ther , vol.12 , pp. 22-34
    • Mayer, M.D.1    Khosravan, R.2    Vernillet, L.3    Wu, J.T.4    Joseph-Ridge, N.5    Mulford, D.J.6
  • 43
    • 33746865996 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects
    • Khosravan R, Grabowski BA, Wu JT, Joseph-Ridge N, Vernillet L. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects. Clin Pharmacokinet 2006; 45: 821-841.
    • (2006) Clin Pharmacokinet , vol.45 , pp. 821-841
    • Khosravan, R.1    Grabowski, B.A.2    Wu, J.T.3    Joseph-Ridge, N.4    Vernillet, L.5
  • 44
    • 10344260696 scopus 로고    scopus 로고
    • Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serumurate in healthy volunteers
    • Becker MA, Kisicki J, Khosravan R, Wu J, Mulford D, Hunt B, et al. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serumurate in healthy volunteers. Nucleosides Nucleotides NucleicAcids 2004; 23: 1111-1116.
    • (2004) Nucleosides Nucleotides NucleicAcids , vol.23 , pp. 1111-1116
    • Becker, M.A.1    Kisicki, J.2    Khosravan, R.3    Wu, J.4    Mulford, D.5    Hunt, B.6
  • 45
    • 33751200338 scopus 로고    scopus 로고
    • Acute effects of febuxostat, a nonpurine selective inhibitor ofxanthine oxidase, in pacing induced heart failure
    • Hou M, Hu Q, Chen Y, Zhao L, Zhang J, Bache RJ. Acute effects of febuxostat, a nonpurine selective inhibitor ofxanthine oxidase, in pacing induced heart failure. J Cardiovasc Pharmacol 2006; 5: 255-263.
    • (2006) J Cardiovasc Pharmacol , vol.5 , pp. 255-263
    • Hou, M.1    Hu, Q.2    Chen, Y.3    Zhao, L.4    Zhang, J.5    Bache, R.J.6
  • 46
    • 55149124723 scopus 로고    scopus 로고
    • Xanthine oxidase inhibition with febuxostat attenuates systolicoverload-induced left ventricular hypertrophy and dysfunctionin mice
    • Xu X, Hu X, Lu Z, Zhang P, Zhao L, Wessale JL, et al. Xanthine oxidase inhibition with febuxostat attenuates systolicoverload-induced left ventricular hypertrophy and dysfunctionin mice. J Card Fail 2008; 14: 746-753.
    • (2008) J Card Fail , vol.14 , pp. 746-753
    • Xu, X.1    Hu, X.2    Lu, Z.3    Zhang, P.4    Zhao, L.5    Wessale, J.L.6
  • 47
    • 41149104043 scopus 로고    scopus 로고
    • Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters
    • Hayashi K, Kimata H, Obata K, Matsushita A, Fukata A, Hashimoto K, et al. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters. JCard Fail 2008; 3: 238-244.
    • (2008) JCard Fail , vol.3 , pp. 238-244
    • Hayashi, K.1    Kimata, H.2    Obata, K.3    Matsushita, A.4    Fukata, A.5    Hashimoto, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.